Unpacking Averages: Assessing the Racial Composition of Drug Clinical Trial Subjects | Epstein Becker & Green
The United States Food and Drug Administration (FDA) for many years has been trying to increase the participation of minorities in clinical trials to help ensure that regulated products...
Source: jdsupra.com